Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Teduglutide Recombinant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,732,537Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Entera Bio Reveal Positive PK Data for Oral GLP-2 Tablet at ESPEN
    Entera Bio Reveal Positive PK Data for Oral GLP-2 Tablet at ESPEN

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3150045/0/en/Entera-Bio-Reports-Positive-PK-Data-for-First-in-Class-Oral-GLP-2-Tablet-Treatment-for-Patients-with-Short-Bowel-Syndrome-at-the-2025-ESPEN-Congress.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    OPKO, Entera Bio’s Oral GLP-2 Picked for 2025 ESPEN Congress
    OPKO, Entera Bio’s Oral GLP-2 Picked for 2025 ESPEN Congress

    08 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/08/3111697/0/en/OPKO-Health-and-Entera-Bio-Announce-Abstract-on-PK-PD-of-Oral-GLP-2-Tablet-for-the-Treatment-of-Short-Bowel-Syndrome-Selected-for-2025-ESPEN-Congress.html

    GLOBENEWSWIRE
    08 Jul 2025
    Share Share
    Combo drugs: latest trend in local pharmaceuticals
    Combo drugs: latest trend in local pharmaceuticals

    19 Aug 2019

    // Lee Hye-seon KOREAMED

    http://www.koreabiomed.com/news/articleView.html?idxno=6300

    Lee Hye-seon KOREAMED
    19 Aug 2019
    Share Share
    U.S. FDA Approves GATTEX® for Children 1Y Age&Older With Short Bowel Syndrome
    U.S. FDA Approves GATTEX® for Children 1Y Age&Older With Short Bowel Syndrome

    17 May 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/us-fda-approves-gattex-teduglutide-for-children-1-year-of-age-and-older-with-short-bowel-syndrome-sbs-300852294.html

    PR NEWSWIRE
    17 May 2019
    Share Share
    Shire Moves to Protect Gattex From Par Generic Challenge
    Shire Moves to Protect Gattex From Par Generic Challenge

    31 Jul 2018

    // BLOOMBERG

    https://news.bloomberglaw.com/pharma-and-life-sciences/shire-moves-to-protect-gattex-from-par-generic-challenge?context=landing-heroes

    BLOOMBERG
    31 Jul 2018
    Share Share
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.
    Gattex (teduglutide), Amlodipine and Valsartan Tabs : Shire-NPS Pharm v. Par Pharma et al.

    30 Jul 2018

    // PATENT LITIGATION

    https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf

    PATENT LITIGATION
    30 Jul 2018
    Share Share